- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- June 2026
- 371 Pages
Global
From €5310EUR$5,850USD£4,575GBP
- Report
- January 2026
- 60 Pages
Global
From €1135EUR$1,250USD£977GBP
- Report
- May 2026
- 125 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 135 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 160 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- January 2026
- 105 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- May 2026
- 138 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 146 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 136 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- March 2026
- 141 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- March 2026
- 137 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- May 2026
- 180 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- May 2026
- 110 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 180 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 120 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 120 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- April 2026
- 120 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- January 2026
- 120 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- January 2026
- 317 Pages
Global
From €4312EUR$4,750USD£3,714GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more